scholarly journals Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children

2008 ◽  
Vol 7 (1) ◽  
Author(s):  
Elizabeth A Ashley ◽  
Loretxu Pinoges ◽  
Eleanor Turyakira ◽  
Grant Dorsey ◽  
Francesco Checchi ◽  
...  
1997 ◽  
Vol 176 (4) ◽  
pp. 1113-1116 ◽  
Author(s):  
Lorenz von Seidlein ◽  
Shabbar Jaffar ◽  
Margaret Pinder ◽  
Michelle Haywood ◽  
Georges Snounou ◽  
...  

2019 ◽  
Vol 33 (12) ◽  
pp. 14185-14193 ◽  
Author(s):  
Tsin W. Yeo ◽  
Peggy A. Bush ◽  
Youwei Chen ◽  
Sarah P. Young ◽  
Haoyue Zhang ◽  
...  

2004 ◽  
Vol 10 (3) ◽  
pp. 309-314
Author(s):  
I. Adam ◽  
M. H. Ibrahim ◽  
I. A. Aelbasit ◽  
M. I. El Bashir

A prospective clinical trial was carried out to determine in vivo efficacy of sulfadoxine/pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in children in New Halfa. Forty patients were enrolled; 31 completed the 28-day follow-up. Six [19.4%] patients showed recurrence of parasitaemia during follow-up, while the rest [80.6%] cleared the parasites and responded fully to treatment. All the failures were late treatment failures. Parasite genotyping showed that 1 [16.7%] of the 6 cases of late parasitaemia was due to reinfection while the rest [83.4%] were due to true recrudescence. During the follow-up period 22.6% of patients showed gametocytaemia. The high level of treatment failure as well as gametocytaemia necessitates the introduction of artesunate in this combination therapy


2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Helen Kuokuo Kimbi ◽  
Mesame Ntoko ◽  
Nelson N. Ntonifor ◽  
Emmaculate Lum ◽  
Anna L. Njunda ◽  
...  

Artemisinin derivatives are now the most potent and rapidly acting antimalarials. The aim of this study was to assess thein vivoefficacy and tolerability of a combination of Malartin (an artesunate) and sulphadoxine-pyrimethamine (SP) in the treatment of uncomplicated falciparum malaria in Dibanda, Cameroon. A total of 197 subjects were recruited into the study and administered Malartin for 3 days and SP as a single dose on day 0. Only 174 of the subjects were successfully followed up on days 3, 7, and 14. The overall success rate of the drug combination was 92.53%. Parasite density decreased during the follow-up period in different age groups, sexes, and social classes. The prevalence of anaemia decreased from 22.99% at enrolment to 9.77% on day 14, and the difference was significant (P<0.05) on all days of followup. The drug combination did not give rise to any serious side effects.


1999 ◽  
Vol 180 (6) ◽  
pp. 2077-2080 ◽  
Author(s):  
Crispim Cerutti, Jr. ◽  
Rui Rafael Durlacher ◽  
Filomena E. C. de Alencar ◽  
Aluísio A. C. Segurado ◽  
Lorrin W. Pang

Sign in / Sign up

Export Citation Format

Share Document